Primoris Co., Ltd. logo

Primoris Co., Ltd.

Primoris develops 'Delivery Platform can load Effective Substance' and 'Function-enhanced Exosome medicine' with using

2 employees · est. 2019 · Korea South

VS
ReNeuron Group Plc logo

ReNeuron Group Plc

Developing the next generation of Engineered Exosomes.

27 employees · est. 1997 · Bridgend, United Kingdom

ReNeuron Group Plc is the older company (2019 vs 1997); ReNeuron Group Plc is the larger of the two.

Side-by-Side Comparison

Primoris Co., Ltd. ReNeuron Group Plc
Founded
2019 1997 older
Headquarters
Korea South Bridgend, United Kingdom
Employees
2 27 larger
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care, Health and Wellness
Funding Stage
Seed Post Ipo Equity
Total Funding
$3.00B $110.95M
Funding Rounds
1 5
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Delivery Platform, Exosome Medicine, Nanovesicle, Stem Cells, MRNA, R&D, Biopharmaceutical, Business Development, Cancer Treatment, Hair Loss Treatment, Wound Healing Treatment, Pneumonia Treatment, Korean Bio, Drug Delivery Platform, Series A Investment Exosome Technology, CustomEx Platform, Tissue Targeting, Payload Delivery, Cell-specific Targeting, Therapeutic Development, Disease Treatment, Partnership, Drug Delivery, Regenerative Medicine
Website
primoris.co.kr reneuron.com
Primoris Co., Ltd. logo

About Primoris Co., Ltd.

Primoris Co., Ltd. is a biotechnology and pharmaceutical company based in South Korea. Founded in 2019, the company focuses on developing advanced medical solutions. Primoris's slogan, "Primoris develops 'Delivery Platform can load Effective Substance' and 'Function-enhanced Exosome medicine' with u...

ReNeuron Group Plc logo

About ReNeuron Group Plc

ReNeuron Group Plc is a biotechnology startup based in United Kingdom that is dedicated to developing the next generation of Engineered Exosomes. The company's flagship technology, CustomEx exosome platform, is designed to produce exosomes with unique tissue targeting tropisms, allowing for the deli...

We will tell you when either one moves

BounceWatch watches Primoris Co., Ltd. and ReNeuron Group Plc for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Primoris Co., Ltd. and ReNeuron Group Plc — by email.

Frequently Asked Questions

Primoris Co., Ltd. — Primoris develops 'Delivery Platform can load Effective Substance' and 'Function-enhanced Exosome medicine' with using. ReNeuron Group Plc — Developing the next generation of Engineered Exosomes.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Primoris Co., Ltd. has raised $3.00B while ReNeuron Group Plc has raised $110.95M.
Primoris Co., Ltd. and ReNeuron Group Plc operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Primoris Co., Ltd. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Primoris Co., Ltd. on 12 Sep 2024, and ReNeuron Group Plc on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy